Zantac
Zantac, also known by its generic name, ranitidine, is a prescription and over-the-counter heartburn and ulcer medication used by millions of Americans. Zantac has recently been pulled from store shelves by the U.S. Food and Drug Administration (FDA) due to concerns over its harmful effects on human health. It has been revealed that Zantac contains a contaminant knows as NDMA, which has been identified by the FDA and the World Health Organization as a probable human carcinogen linked to diseases such as liver and stomach cancer. Further research into this toxic substance is beginning to establish connections to many other types of cancer as well. Although the manufacturers of Zantac such as Sanofi were aware of this fact, they chose not to disclose the information to their customers.
Due to these overwhelming health concerns the FDA recalled Zantac from the consumer market on April 1, 2020, along with all other ranitidine products. The immediate FDA recall applies to both prescription and over-the-counter Zantac medications.
Fears Nachawati is currently helping people across the country who have been hurt by this harmful drug. Our law firm has extensive experience holding those in the pharmaceutical industry accountable who have repeatedly put profit above their customers’ health and safety. If you or a loved one developed cancer after taking the drug Zantac, please call the experienced attorneys at Fears Nachawati for a free consultation. We will provide you with a no-obligation review of your case, explain your legal options, and help you plan a path forward. For more information, call us at (866) 705-7584, or email us at help@fnlawfirm.com. We’ve helped thousands of individuals in your position and we are ready to help you too.